---
title: "Pre-market hot trades in US stocks: Innovation Beverage down 7.03% in pre-market; Murano Global BV up 3.89% in pre-market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274163322.md"
description: "Innovation Beverage pre-market down 7.03%; Murano Global BV pre-market up 3.89%; TEN pre-market up 64.31%; Digital Currency X Tech pre-market up 37.58%; Serina Therapeutics pre-market up 33.46%"
datetime: "2026-01-29T14:02:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274163322.md)
  - [en](https://longbridge.com/en/news/274163322.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274163322.md)
---

# Pre-market hot trades in US stocks: Innovation Beverage down 7.03% in pre-market; Murano Global BV up 3.89% in pre-market

**Pre-market Hot Trades in US Stocks**

Innovation Beverage is down 7.03% in pre-market trading. Based on recent key news:

1.  On January 28, Innovation Beverage Group announced a five-for-one reverse stock split. This will take effect on January 30, leading to a drop in stock price. The company's shares will continue to trade on NASDAQ, with the number of shares reduced from 3,470,331 to 694,066. Source: Reuters
    
2.  On January 28, the trading volume of Innovation Beverage Group increased, and the market's reaction to the reverse stock split led to a decline in stock price. Source: Benzinga
    
3.  On January 28, the average short interest in the industry was 5.16%, while Innovation Beverage Group's short interest was lower, indicating a lack of market confidence in its stock. Source: Benzinga The industry faces policy changes, and risks need to be monitored.
    

Murano Global BV is up 3.89% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.

**Top Gainers in Pre-market US Stocks**

TEN is up 64.31% in pre-market trading. Based on recent key news:

1.  On January 27, TEN Holdings announced a capital restructuring to repay debt and regain NASDAQ compliance. This move provides some support for the company but does not fully offset its financial and technical weaknesses. Nevertheless, the market's positive reaction to its capital restructuring has driven the stock price significantly higher.
    
2.  On January 26, analysts issued a strong sell recommendation on TEN Holdings' technical signals, mainly due to its trading far below key moving averages and negative momentum. Despite this, the market has shown optimism towards its recent corporate actions, leading to a rise in stock price.
    
3.  On January 25, TEN Holdings' market valuation was constrained by ongoing losses and lack of dividend support. However, the recent capital restructuring actions provided short-term upward momentum for its stock price. Recent volatility in US stocks requires cautious investment.
    

DCX is up 37.58% in pre-market trading. Based on recent key news:

1.  On January 29, Digital Currency X Technology announced that it has re-complied with NASDAQ's minimum market capitalization requirements. This news confirms that the company has met the standards over the past 20 trading days, alleviating market concerns about its delisting risk and driving the stock price up.
    
2.  On January 26, the company implemented a 12-for-1 stock consolidation to meet NASDAQ's minimum bid requirements. This move increased the price per share, boosting investor confidence and promoting a rise in stock price On January 27, despite receiving a delisting notice from Nasdaq, subsequent compliance announcements alleviated market panic, leading to a rebound in stock prices. The digital asset industry has experienced significant volatility recently.
    

Serina Therapeutics rose 33.46% in pre-market trading. Based on recent key news:

1.  On January 28, Serina Therapeutics announced that its drug SER-252 for the treatment of advanced Parkinson's disease received IND application approval from the FDA. This news drove the company's stock price up significantly by 33.46% in pre-market trading. Source: Reuters
    
2.  On January 28, Benzinga's stock ranking indicated that Serina Therapeutics had a negative price trend across all time frames. This rating may have a certain impact on investor confidence. Source: Benzinga The biopharmaceutical industry has also experienced significant volatility recently, and investors should exercise caution

### Related Stocks

- [IBG.US](https://longbridge.com/en/quote/IBG.US.md)
- [MRNO.US](https://longbridge.com/en/quote/MRNO.US.md)

## Related News & Research

- [Beyond SPY: Active ETFs Poised To Lead Next Phase Of $25 Trillion Industry Boom](https://longbridge.com/en/news/282571072.md)
- [A Look At Texas Pacific Land (TPL) Valuation After Murray Stahl’s Passing And Recent Share Price Volatility](https://longbridge.com/en/news/282424137.md)
- [Hidden costs of war: $8 trillion spent, trillions more in debt & long-term impact](https://longbridge.com/en/news/282735241.md)
- [Mondelez International, Inc. $MDLZ Holdings Lowered by Burney Co.](https://longbridge.com/en/news/282803860.md)
- [Exploring 3 European Small Cap Gems with Promising Potential](https://longbridge.com/en/news/282492702.md)